Packed red blood cells: Difference between revisions

No edit summary
Line 1: Line 1:
==General==
*Type:
*Dosage Forms:
*Common Trade Names:
==Adult Dosing==
*One unit (250mL) raises hemoglobin by 1 g/dl
**Usually transfuse at least 2 units at a time (15mL/kg in peds)
*Must transfuse no slower than 1 unit/4hr
**If require slower transfusion (e.g. risk for volume overload) the pRBC can be split
==Pediatric Dosing==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*Lactation:
*Renal Dosing
**Adult
**Pediatric
*Hepatic Dosing
**Adult
**Pediatric
==Features==
==Features==
*Can give type O Rh-positive pRBCs to a man or woman no longer of child-bearing age
*Can give type O Rh-positive pRBCs to a man or woman no longer of child-bearing age
Line 17: Line 40:
*Symptomatic anemia or cardiopulmonary disease AND Hb <10
*Symptomatic anemia or cardiopulmonary disease AND Hb <10


==Dose==
==Contraindications==
*One unit (250mL) raises hemoglobin by 1 g/dl
*Allergy to class/drug
**Usually transfuse at least 2 units at a time (15mL/kg in peds)
 
*Must transfuse no slower than 1 unit/4hr
==Adverse Reactions==
**If require slower transfusion (e.g. risk for volume overload) the pRBC can be split
===Serious===
 
===Common===
 
==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:
*Mechanism of Action:


==See Also==
==See Also==
*[[Transfusions]]
*[[Transfusions]]


==Source==
==References==
Tintinalli
<references/>
 
[[Category:Drugs]]
[[Category:Drugs]]
[[Category:Heme/Onc]]
[[Category:Heme/Onc]]

Revision as of 17:39, 29 May 2015

General

  • Type:
  • Dosage Forms:
  • Common Trade Names:

Adult Dosing

  • One unit (250mL) raises hemoglobin by 1 g/dl
    • Usually transfuse at least 2 units at a time (15mL/kg in peds)
  • Must transfuse no slower than 1 unit/4hr
    • If require slower transfusion (e.g. risk for volume overload) the pRBC can be split

Pediatric Dosing

Special Populations

  • Pregnancy Rating:
  • Lactation:
  • Renal Dosing
    • Adult
    • Pediatric
  • Hepatic Dosing
    • Adult
    • Pediatric

Features

  • Can give type O Rh-positive pRBCs to a man or woman no longer of child-bearing age
  • Options:
    • Leukocyte reduced
      • Eliminates 70-85% of leukocytes
      • Reduces nonhemolytic febrile reactions
      • Prevents sensitization in pts who may require bone marrow transplant
      • Minimizes risk of HIV and CMV infection
    • Irradiated
      • Eliminates capacity of T-cells to proliferate (prevents graft-versus-host disease)
      • Consider in transplant pts, neonates and immunocompromised patients
    • Washed
      • Indicated for pts w/ hypersensitivity to plasma (such as IgA deficiency)

Indications

  • Acute hemorrhage or chronic anemia with Hb <6
  • Symptomatic anemia or cardiopulmonary disease AND Hb <10

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

See Also

References